Since 2020, Equity Forward has conducted investigative research on anti-abortion centers (AACs) and how states have financially supported and legitimized them through Alternatives to Abortion (A2A) programs. Our new research provides, for the first time, a full funding portrait of public dollars invested into A2A programs and individual AACs at the state level since the practice began.
SCOTUS heard oral arguments for FDA v. Alliance for Hippocratic Medicine on March 26, 2024, with a decision likely to be released in June. Importantly, SCOTUS will hear cert petitions from the FDA and Mifeprex manufacturer Danco Laboratories, but not the Alliance for Hippocratic Medicine. Due to a stay issued by the U.S.
Anti-abortion centers (AACs) exist solely to deter pregnant people from receiving abortions and comprehensive reproductive health care.
On December 1, 2021, the Supreme Court will hear arguments for Dobbs v. Jackson Women’s Health Organization. The case will weigh a Mississippi abortion ban and call into question the future of Roe v. Wade. In anticipation of Roe being overturned and abortion clinics subsequently being forced to close, anti-abortion centers (AACs) claim they are ready to absorb the burdens of people forced to carry a pregnancy to term.